[1] Ponikowski
P, Voors AA, Anker SD, et al. 2016 ESC Guidelines for the diagnosis and
treatment of acute and chronic heart failure: the task force for the diagnosis
and treatment of acute and chronic heart failure of the European Society of
Cardiology (ESC). Developed with the special contribution of the Heart Failure
Association (HFA) of the ESC[J]. Eur J Heart Fail, 2016, 18(8):891-975. DOI:
10.1002/ejhf.592.
[2] 杨杰孚,王华,柴坷.2018中国心力衰竭诊断和治疗指南亮点[J].中国心血管病研究,2018,16(12):1057-1060. DOI:10.3969/j.issn.1672-5301.2018.12.001.
[3] Boonman-de Winter LJ, Rutten FH, Cramer
MJ, et al. High prevalence of previously unknown heart failure and left
ventricular dysfunction in patients with type 2 diabetes[J]. Diabetologia,
2012, 55(8):2154-2162. DOI: 10.1007/s00125-012-2579-0.
[4] Kim MK, Kim B, Lee JY, et al. Tissue
Doppler-derived E/e' ratio as a parameter for assessing diastolic heart failure
and as a predictor of mortality in patients with chronic kidney disease[J].
Korean J Intern Med, 2013, 28(1):35-44. DOI: 10.3904/kjim.2013.28.1.35.
[5] Han SS, Cho GY, Park YS, et al.
Predictive value of echocardiographic parameters for clinical events in
patients starting hemodialysis[J]. J Korean Med Sci, 2015, 30(1):44-53. DOI:
10.3346/jkms.2015.30.1.44.
[6] Li N, Zhou H, Tang Q. Red blood cell
distribution width: a novel predictive indicator for cardiovascular and
cerebrovascular diseases[J]. Dis Markers, 2017, 2017:7089493. DOI:
10.1155/2017/7089493.
[7] Hu ZD, Lippi G, Montagnana M. Diagnostic
and prognostic value of red blood cell distribution width in sepsis: a
narrative review[J]. Clin Biochem, 2020, 77:1-6. DOI:
10.1016/j.clinbiochem.2020.01.001.
[8] Lippi G, Cervellin G, Sanchis-Gomar F.
Red blood cell distribution width: a marker of anisocytosis potentially
associated with atrial fibrillation[J]. World J Cardiol, 2019, 11(12):292-304.
DOI: 10.4330/wjc.v11.i12.292.
[9] Yeh HC, Lin YT, Ting IW, et al.
Variability of red blood cell size predicts all-cause mortality, but not
progression to dialysis, in patients with chronic kidney disease: a 13-year
pre-ESRD registry-based cohort[J]. Clin Chim Acta, 2019, 497:163-171. DOI:
10.1016/j.cca.2019.07.035.
[10] Zhang T, Li J, Lin Y, et al. Association
between red blood cell distribution width and all-cause mortality in chronic
kidney disease patients: a systematic review and meta-analysis[J]. Arch Med
Res, 2017, 48(4):378-385. DOI: 10.1016/j.arcmed.2017.06.009.
[11] Celik A, Koc F, Kadi H, et al.
Relationship between red cell distribution width and echocardiographic
parameters in patients with diastolic heart failure[J]. Kaohsiung J Med Sci,
2012, 28(3):165-172. DOI: 10.1016/j.kjms.2011. 06.024.
[12] Senthong V, Hudec T, Neale S, et al.
Relation of red cell distribution width to left ventricular end-diastolic pressure
and mortality in patients with and without heart failure[J]. Am J Cardiol,
2017, 119(9):1421-1427. DOI: 10.1016/j.amjcard.2017.01.036.
[13] Pichler G, Haller MC, Kainz A, et al.
Prognostic value of bone- and vascular-derived molecular biomarkers in
hemodialysis and renal transplant patients: a systematic review and
meta-analysis[J]. Nephrol Dial Transplant, 2017, 32(9):1566-1578. DOI:
10.1093/ndt/gfw387.
[14] Isakova T, Cai X, Lee J, et al.
Longitudinal FGF23 trajectories and mortality in patients with CKD[J]. J Am Soc
Nephrol, 2018, 29(2):579-590. DOI: 10.1681/ASN.2017070772.
[15] van Breda F, Emans ME, van der Putten K,
et al. Relation between red cell distribution width and fibroblast growth
factor 23 cleaving in patients with chronic kidney disease and heart
failure[J]. PLoS One, 2015, 10(6):e0128994. DOI: 10.1371/journal.pone.0128994.
|